Tag: cancer
-
Enhanced Gene Therapy Boosts Anti-Tumor Response
Gene therapies delivered with electronic pulses were shown in lab mice to increase production of natural immune-system proteins and reduce melanoma, or advanced skin cancer, tumors.
-
Trial Underway to Test Cancer Immunotherapy Aid
A clinical trial began recruiting participants with advanced tumors to test a compound that helps treatments for cancer harnessing the immune system.
-
Cancer Blood Test Company Raises $65M in Early Funds
Freenome, a company applying machine learning to analysis of liquid biopsies, is raising $65 million in its first round of venture financing.
-
Engineered T-Cells Shown Reducing Non-Hodgkin Lymphoma
A clinical trial testing synthetic immune system cells shows after 6 months the cells can generate a full or partial response in many patients with non-Hodgkin lymphoma.
-
Trial Begins Testing Enhanced Cord Blood Stem Cells
A clinical trial testing transplant grafts derived from umbilical cord blood as an alternative to bone marrow stem cells for people with blood-related cancers is treating its first patient.
-
Test of Nasal Skin Cells Found to Detect Lung Cancer
A diagnostic test analyzing the genes in skin cells from nasal passages can detect lung cancer, and the absence of cancer, as accurately as more invasive samples from the airways.
-
Nuclear Cancer Therapy Company Launches, Raises $25M
A new company developing cancer therapies combining nuclear radiation and synthetic antibodies is starting up in Hamilton, Ontario.
-
Tissue Regeneration Start-Up Gains $33M in Early Funds
A new enterprise founded by researchers at Stanford University aims to discover and develop drugs that repair and regenerate tissue from stem cells.
-
Skin Health Data Collected by App Offered for Research
A smartphone app collecting images and data about moles on the skin of volunteers is now available to researchers for studies of cancer and other disorders.
-
Cancer Drug Shown to Improve Survival Time in Dogs
A drug to treat a deadly cancer in dogs was shown in a clinical trial to extend the survival time of canine patients by 6 months or more, with potential applications in humans.